Tyratech Share Discussion Threads

[haroldthegreat] 17/9/2014 21:45

went into superdrug in harrow today could not see any stock on display and pharmacist did not know about it. then went into sainsburys in stanmore and the pharmacy staff had not heard of it,
that shows how good the distribution is.
in reality lice products sell throughout the year. there is a slight peak now as the kids go back to school but kids catch them all the time.

[sidam] 17/9/2014 10:47

As the company informed gemf, there is no problem with the use of the terminix band name.

It is also almost self evident why Bruno does not spend time on discussing the JV. It will have no negative effect as AMVAC finance it, but there will be no positive impact until probably 2017 at the earliest.

So in the short term it is of little importance.

Anyway, we will get an update on 25th when TYR announce their results with the roadshow the next week.

[gemferret] 16/9/2014 10:41

Somerset

You are talking about a date pre the problem arising. Alan Reade mentioned Envance on 27th July (tips TV).

The CEO in his recent interview posted here, doesn't mention it at all.

The reason I ignore it is down to the products not being available. The only product left in Walmart was the stinging insect spray.

Home depot seemed to have some products but have a search now and you will find they have nothing related to Tyra products listed at all.

That tells me as suspected at the time that the Terminix deal, is for whatever reason, dormant, suspended, or dead.

As the company and nomad won't answer questions on the topic we have to find out for ourselves or ignore it exists.

Envance has two trademark registrations. One it gave up on after a court challenge by BASF. The other is being contested by BASF. A recent extension date passed, so I'm just waiting to see if there is an update.

I was looking, and now has become very clear that the Terminix products are not being supplied to retailers, and all we are seeing re the stinging insect product in Walmart is what is left on shelves.

There will be little demand for it during winter.

Amvac may have other plans and Tyra have the cover of only having 40% of the deal, so they are not obliged to report anything.

It's down to Amvac to report on Terminix and due to their size it's not material. All we will get is some indication of potential revenue in results, which looks like it will be very close to nowt.


You can be sure that any fund invested, or looking to invest will know the above.

More fund raising looks nailed on. That share prophets article looks way off for revenue this year, and is probably out there to try and get PIs buying while those boys sell and pocket profits. That's what they do.

I think this is a great looking company, but with high short term costs v revenue.

There is no guarantee the Novartis products will gain a good share of the market, but I think the prospects are good.

Some products are seasonal, and in the current supply sectors we are now heading into winter where most products won't be in demand.

Vamousse could be but it's a late entry (UK) into a short season product.

500,000 selling won't cover the salaries, let alone 10's of 1000's.

It's not a company that grabs market attention. Buyers may make it spike but until sales seriously kick in and are proven it won't attract serious attention.

Funds may like it, but more fund raising seems an absolute certainty and they will get their fill that way.

AMVAC own a big chunk, so I'll be interested to see how the JV progresses or not.

[somerset lad] 15/9/2014 15:37

I don't think anyone has posted the slides and transcript of the AMVAC shareholders meeting of 4 June 2014: see the top right corner of

This explains that:

1. Envance is no longer exclusively distributed by Home Depot. It is now distributed through 11 retailers and is in three times as many stores.

2. AMVAC is working on combining TYR's technology with its own for crop protection applications.

AMVAC then gave Bruno the floor at their shareholders meeting.

It doesn't look as though the relationship is in difficulties.

[corrientes] 15/9/2014 08:48

Why they don't advertise on local radio stations, which would attract a lot more attention IMO, and cost less, beats me.

[21trader] 14/9/2014 19:48

Fair comments harold.

I guess those that advertise have to charge more for their products that is the industry.

People will still think the more expensive products are the most effective and may well be that in this case. You also have to consider the amount of money spent in research and development that needs to be recouped.

[haroldthegreat] 14/9/2014 19:34

most people ask their pharmacist for advice. family of 4 gets 2 large bottles of hedrin for 22£ does 2 treatments for long haired family . 2 short hair males and 2 long haired females. vamousse i can per head 4 cans 64£ for the family. if they get re-infected by one of their lousy friends another £16 can is required. if the ad is good they might get good initial sales. if the person is reinfected and they have to buy it again they are going to ask their pharmacist for something cheaper and will not ever repurchase vamousse. a £64 hit to their budget is too much.
as far as ad campaigns are concerned all the companies advertise this time of year as the lousy kids that caught their lice 10 weeks previously are beginning to scratch their heads before going back to school. my main objection to this product is the premium price. if they hadnt been so greedy the could have taken the market. i am assuming the product does work but it will be the public reporting back that will show what they think of it.
just for the record i have put an order in for a few cans so that if anyone comes in for it i make the £64 sale. i will not recommend it until i get feedback from patients.
there is a difference between serving, they get what they ask for and selling where one recommends a product where one knows it works and actively sell it.

[21trader] 14/9/2014 18:25

Yes seemed the Vamousse hype has worried Lyclear and they started doing their own adverts as well but not as catchy as Vamousse but they seem the main competitor simply because they are the only one that is advertising on Tv as well.

[corrientes] 14/9/2014 18:18

Lyclear advertisied on 47

[21trader] 14/9/2014 15:45

Gemferret

Really hard to guess sales. Tyr were keen to drop snippets in the early days now they are tight lipped. With 4000 stores how many V's have been sold by their comment they made then

"Vamousse Lice Treatment is available at Walmart, where it's been flying off the shelves across the country since it went on the market in April. The treatment and a new shampoo, Vamousse Lice Prevention, which is designed to prevent head lice, also will be on sale starting Monday on Amazon.com"

[21trader] 14/9/2014 15:41

Nope. Will do next week.

[baxter99] 14/9/2014 15:36

Did you have a look at the packaging - does it still say "homeopathic"?

[baxter99] 14/9/2014 15:30

I guess you didn't ask if they had sold any?

[21trader] 14/9/2014 15:26

Was in a tiny Boots yesterday in a remote town and they had Vamousse stocked
which is good to see.

[gemferret] 14/9/2014 09:35

Still lurking and getting a getting grip of this now.

It looks like it is a company with great prospects, but then why aren't the major buyers out there. What it currently has is PI spike buying on any news, and that's it.

The funds and larger investors are not buying as it seems there will be another bout of fund raising near term, they got them at 7p last time. The spikes suggest shares are tight so they can't get them on the market (if they want them)

Why more funding?

Tyr reported this for the last funding, with about 700k in the bank at the time

◦£1.5 million to support the launch of the Vamousse product range in Boots and Superdrug in the UK through a focused marketing campaign and to build up the appropriate inventory;
◦£1.2 million for further anticipated listings in additional US and UK retailers as well as expansion into further new geographic regions; and
◦£0.6 million for additional working capital.

So 600k left for additional working capital on top of the 700k.

Last results

$2.8 mill General which will include salaries
$430k business development
$1.75 mill R and D.

That's a $400k per month burn rate.

I note the talk of 10's of 1000's of the Vamousse product sold. Call it 80,000 and £5 profit per unit and you have £400k ($650). So 6 weeks worth of the cash burn rate.

However I think they have a supply problem as Superdrug while listing it seems to show they have no stock. Boots doesn't appear to list it currently.

Going back to the fund raising comment.

'and to build up the appropriate inventory;'

So it seems they don't have the supply capacity at the moment but will do in the future.

The head lice season is short in terms of product demand. 10's of 1000's and 100's of 1000's are nowhere near enough to cover costs. That's ignoring the months of payment lag from the partners they are with.

Then of course there are plenty of other products out there. I know Vamousse seems far better, but I have had success with the other products, and know it they cover multiple treatments, not just one per child.

So there is quite a lot of cash needed yet whether through debt or dilution, in the coming months. There is no way sales are going to cover costs.

Guardian, although launched won't see winter sales, that will be a spring/summer product

Anyone any idea of the likely amount they will need. My guess is $5 to $10 mill overall before Tyr can get to positive cash flow.

They have done about $5.4 mill this year so far, the first one earlier in the year included the comment to build an appropriate Vamousse inventory, which would have been the US side.

They also said this on the last one

'as well as expansion into further new geographic regions'

So they will need funds for the inventory for those areas and other points to.

I completely ignore the Envance now, as I see virtually no revenue coming from that direction. I really like the Novartis deal, but it will take time to gain traction in the market, but should do very well.

As for now, it's going to be PI spike buying and selling and hype, funds simply won't get involved as it seems for sure another round or two of fund raising is coming.

[windass] 09/9/2014 12:54

Tyratech shares set to double?

[pugugly] 08/9/2014 07:27

Gek:> Thanks - sounds liek typical UK multiples buying pattern for new products - Place in a few stores and only extend distribution if it meets their own profit per linear foot criteria. Teh level of distributionwill make or break the coy.

[gekko68] 07/9/2014 17:35

There products are stocked at all walmart stores. It can also be bought on line at Walmart. I believe it can only be bought at selected stores at Supper-drug,the larger ones. Tesco have it in there stock book at the Pharmacy,however it is not yet available on the shelf. Could be bought at boots at my local store. I don't think they will talk about numbers,as it is market sensitive information. However when i phoned there Vamousse help line,i asked about sales. They said they where surprised about how well there products where selling. If you don't believe me give them a phone. T: 0800 652 7150

[pugugly] 07/9/2014 17:01

What was never stated in the stockints rns (unless I missed it) was the "depth" of distribution within the listed stockists - Could well be just limited number of test stores -

Next time anyone talking to the coy may I suggest that this question is asked.

[gekko68] 07/9/2014 15:48

Yes i agree,its a product that needs to be available when needed. Have only found it in boots. Purchasing on line & waiting for it is not practicable. If you go to the Vamousse web site & click on the Twitter link,you would be surprised that there are some well known people who are followers.
Kirstie Mary Allsopp. She does allot of tv work,doing up houses etc.

[21trader] 07/9/2014 15:13

The flip side of that though is you need it quickly in the US you can nip down to Walmart. You need it quickly here your best bet is online as the most of the smaller outlets are not stocking it here as of yet so online will be better here
than across the pond or that is my take on it.